88IV - PR Newswire Asia's news - Health Care/Hospital


Published Clinical Study Illustrates Benefits of Promentum® Recover as Low-Dose Solution for Post Exercise Recovery MOMENCE, Ill. , April 23, 2026 /PRNewswire/ -- A recently published human clinical study demonstrates that Promentum® Recover, a patent-pending formula from FutureCeuticals anchored by calcium ... 2026-04-23T Health Care/Hospital Medical/Pharmaceuticals
So-Young International Inc. Files Its Annual Report on Form 20-F BEIJING , April 23, 2026 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers ... 2026-04-23T Cosmetics & Personal Care Health Care/Hospital Household/Consumer/Cosmetics
Fosun Health Strengthens Regional Presence at GlobalHealth Asia-Pacific Forum 2026, Showcasing "China Solution" and Winning Three Major Awards JAKARTA, Indonesia , April 23, 2026 /PRNewswire/ -- Fosun Health made a prominent debut at the GlobalHealth Asia-Pacific Healthcare Insights & Leadership Forum 2026, held alongside the GlobalHealth ... 2026-04-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals Travel
Mabwell Initiates Phase III Clinical Study of its Nectin-4-Targeting ADC 9MW2821 for the Treatment of Triple-Negative Breast Cancer SHANGHAI , April 23, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announces the initiation of a Phase III clinical ... 2026-04-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
2026 ASCO \| Mabwell to Present Latest Clinical Data on 9MW2821 Combined with Toripalimab for Urothelial Carcinoma in Oral and Poster Presentations SHANGHAI , April 23, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that two latest clinical study results ... 2026-04-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia Minjuvi ® (tafasitamab), in combination with rituximab and lenalidomide, is the first and only chemotherapy-free CD19 and CD20 dual-targeted immunotherapy combination regimen to be approved in ... 2026-04-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
WuXi Biologics Receives South Korea MFDS GMP Certification to Enable Commercial Manufacturing of Bispecific Antibody Therapeutics WUXI, China , April 23, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manufacturing ... 2026-04-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
AACR 2026 \| Abbisko Therapeutics Showcases Six Research Advances Highlighting pan-KRAS, 4th Generation EGFR, and Synthetic Lethality Approaches SAN DIEGO , April 23, 2026 /PRNewswire/ -- Abbisko Therapeutics (HKEX: 02256) announced that the company presented six latest preclinical and translational research findings in poster sessions at the American ... 2026-04-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
2026 ASCO Preview \| Alphamab Oncology to Present Clinical Data of TROP2/HER3 Bispecific ADC JSKN016 for HER2-Negative Breast Cancer SUZHOU, China , April 23, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the results from a Phase I clinical study (JSKN016-101, NCT06592417) of its first-in-class ... 2026-04-23T Health Care/Hospital Medical/Pharmaceuticals
BioEngine Launches UltraFeed CHO Supplement, Boosting Titers by Up to 48% SHANGHAI , April 23, 2026 /PRNewswire/ -- Shanghai BioEngine Sci-tech Co., Ltd. announced the launch of UltraFeed, a next-generation fed-batch supplement designed to elevate CHO cell productivity ... 2026-04-23T Biotechnology Computer/Electronics Health Care/Hospital

PR Newswire Asia's news > Health Care/Hospital